Europe Left Ventricular Assist Device Market: By Product Type, By Therapy Therapy, Destination Therapy, Bridge-To-Candidacy Therapy, Bridge-To-Recovery Therapy)), By End User and Country
Europe Left Ventricular Assist Device Market size is estimated to be valued at US$ 162.9 million in 2021 and poised to grow at a significant CAGR of 12.1% over 2022-2028 owing to rising incidence of heart failure, increase in the implantation of left ventricular assist devices, technological advancements, a significant number of ongoing clinical trials focusing on ventricular assist devices, particularly LVADs. An increase in the prevalence of heart failure is one of the major factors surging the growth of the left ventricular assisted devices market across Europe.Europe Left Ventricular Assist Device is a mechanical pump implanted inside a person's chest to help a weakened heart pump blood. An LVAD is different from an artificial heart.
An artificial heart replaces the weak heart permanently, while an LVAD works with the heart to aid it in pumping more blood with less work. It does this by incessantly taking blood from the left ventricle and moving it to the aorta, bringing oxygen-rich blood throughout the body. Healthcare professionals implant this device as a treatment option for severe heart conditions such as heart failures, and chronic cardiac function disorders. In Europe, as of 2015, 15 million people are living with heart failure, and it is one of the few cardiovascular conditions whose prevalence continues to rise over the future. According to a research study in 2015, the estimated prevalence of heart failure in Germany based on health care claims data of over 3 million inhabitants was 4% for both men and women
In Feb 2020, Abbott announced that it had won a breakthrough tag for a fully implantable LVAD system. The device is intended for use in people with advanced heart failure who would otherwise need a heart transplant to pump blood from the heart to the rest of the body.
Geriatric populations are most prone for heart failure disease. Increase in the geriatric population in the Europe region also surge the heart failure cases over the forecast years. For instance, According to Eurostat data, the population aging 65 years and above gradually increased from 2009 to 2020 and in 2020, more than one fifth (20.3 %) of the EU-27 population was aged 65 and over and In 2050, older persons are expected to account for 35% of the population in Europe. Moreover, in UK currently there are nearly12 million people aged 65 and above and the number of centenarians living in the UK has increased 85% in the past 15 years. By 2030 it is anticipated there will be over 21,000 centenarians across the United Kingdom.
|
Report Benchmarks |
Details |
|
By Product Type |
|
|
By Therapy |
|
|
By End User |
|
Download Free Sample Report
The Europe Left Ventricular Assist Device Market size is estimated to be valued at US$ 162.9 million in 2021
Abbott Laboratories, Medtronic, Berlin Heart GmbH, CorWave SA
| 1.Executive Summary |
| 2. Europe Left Ventricular Assist Device Market Introduction |
| 2.1. Europe Left Ventricular Assist Device Market - Taxonomy |
| 2.2. Europe Left Ventricular Assist Device Market - Definitions |
| 2.2.1.Product Type |
| 2.2.2.Therapy |
| 2.2.3.End User |
| 2.2.4.Country |
| 3. Europe Left Ventricular Assist Device Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4. Europe Left Ventricular Assist Device Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Europe Left Ventricular Assist Device Market By Product Type , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Heart Pump |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Controller, |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Batteries, |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Wires |
| 5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 6. Europe Left Ventricular Assist Device Market By Therapy, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Bridge-To-Transplant (BTT) Therapy |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Destination Therapy |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Bridge-To-Candidacy (BTC) Therapy |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Bridge-To-Recovery (BTR) Therapy) |
| 6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 7. Europe Left Ventricular Assist Device Market By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. Pharmaceutical & Medical Device Company |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Laboratories |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Hospitals |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Clinics |
| 7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Others |
| 7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8. Europe Left Ventricular Assist Device Market By Country, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. Germany |
| 8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. France |
| 8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Italy |
| 8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. United Kingdom (UK) |
| 8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Spain |
| 8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9.Germany Left Ventricular Assist Device Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Heart Pump |
| 9.1.2.Controller, |
| 9.1.3.Batteries, |
| 9.1.4.Wires |
| 9.2. Therapy Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Bridge-To-Transplant (BTT) Therapy |
| 9.2.2.Destination Therapy |
| 9.2.3.Bridge-To-Candidacy (BTC) Therapy |
| 9.2.4.Bridge-To-Recovery (BTR) Therapy) |
| 9.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Pharmaceutical & Medical Device Company |
| 9.3.2.Laboratories |
| 9.3.3.Hospitals |
| 9.3.4.Clinics |
| 9.3.5.Others |
| 10.France Left Ventricular Assist Device Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Heart Pump |
| 10.1.2.Controller, |
| 10.1.3.Batteries, |
| 10.1.4.Wires |
| 10.2. Therapy Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Bridge-To-Transplant (BTT) Therapy |
| 10.2.2.Destination Therapy |
| 10.2.3.Bridge-To-Candidacy (BTC) Therapy |
| 10.2.4.Bridge-To-Recovery (BTR) Therapy) |
| 10.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Pharmaceutical & Medical Device Company |
| 10.3.2.Laboratories |
| 10.3.3.Hospitals |
| 10.3.4.Clinics |
| 10.3.5.Others |
| 11.Italy Left Ventricular Assist Device Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Heart Pump |
| 11.1.2.Controller, |
| 11.1.3.Batteries, |
| 11.1.4.Wires |
| 11.2. Therapy Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Bridge-To-Transplant (BTT) Therapy |
| 11.2.2.Destination Therapy |
| 11.2.3.Bridge-To-Candidacy (BTC) Therapy |
| 11.2.4.Bridge-To-Recovery (BTR) Therapy) |
| 11.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Pharmaceutical & Medical Device Company |
| 11.3.2.Laboratories |
| 11.3.3.Hospitals |
| 11.3.4.Clinics |
| 11.3.5.Others |
| 12.United Kingdom (UK) Left Ventricular Assist Device Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Heart Pump |
| 12.1.2.Controller, |
| 12.1.3.Batteries, |
| 12.1.4.Wires |
| 12.2. Therapy Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Bridge-To-Transplant (BTT) Therapy |
| 12.2.2.Destination Therapy |
| 12.2.3.Bridge-To-Candidacy (BTC) Therapy |
| 12.2.4.Bridge-To-Recovery (BTR) Therapy) |
| 12.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Pharmaceutical & Medical Device Company |
| 12.3.2.Laboratories |
| 12.3.3.Hospitals |
| 12.3.4.Clinics |
| 12.3.5.Others |
| 13.Spain Left Ventricular Assist Device Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 13.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Heart Pump |
| 13.1.2.Controller, |
| 13.1.3.Batteries, |
| 13.1.4.Wires |
| 13.2. Therapy Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Bridge-To-Transplant (BTT) Therapy |
| 13.2.2.Destination Therapy |
| 13.2.3.Bridge-To-Candidacy (BTC) Therapy |
| 13.2.4.Bridge-To-Recovery (BTR) Therapy) |
| 13.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Pharmaceutical & Medical Device Company |
| 13.3.2.Laboratories |
| 13.3.3.Hospitals |
| 13.3.4.Clinics |
| 13.3.5.Others |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.Abbott Laboratories |
| 14.2.2.Medtronic |
| 14.2.3.Berlin Heart GmbH |
| 14.2.4.CorWave SA |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.
Download Free Sample
